Silver Book Fact

Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.

Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. NEJM. 2005; 353(17): 84-92. http://www.nejm.org/doi/full/10.1056/NEJMoa050518

Reference

Title
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Publication
NEJM
Publication Date
2005
Authors
Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al.
Volume & Issue
Volume 353, Issue 17
Pages
84-92
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Reductions in mortality for lung, female breast, prostate, and colorectal cancers accounted for 60 to 80 percent of the total decrease in all cancer deaths since the early 1990s.  
  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349…  
  • If the use of recommended colorectal screening increased to 70.5 percent, 1,000 additional lives could be saved each year.